Extensive studies have demonstrated that LncRNA MIAT was abundant in diverse diseases including breast cancer, melanoma and non‐small cell lung cancer, while silencing LncRNA MIAT suppressed cancer cell proliferation, migration and invasion [34–36]. Here, MIAT is linked to lung cancer.